Growth Metrics

Pacific Biosciences Of California (PACB) Net Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -206.25%
Dec 31, 2025 318.27%
Sep 30, 2025 140.64%
Jun 30, 2025 -230.51%
Mar 31, 2025 113.87%
Dec 31, 2024 -4.75%
Sep 30, 2024 -196.27%
Jun 30, 2024 121.71%
Mar 31, 2024 49.81%
Dec 31, 2023 -216.66%
Sep 30, 2023 221.59%
Jun 30, 2023 -604.60%
Mar 31, 2023 39.16%
Dec 31, 2022 443.58%
Sep 30, 2022 95.01%
Jun 30, 2022 -279.05%
Mar 31, 2022 -189.80%
Jun 30, 2021 -155.67%
Mar 31, 2021 6,385.15%
Dec 31, 2020 -48.93%
Sep 30, 2020 198.72%
Jun 30, 2020 -166.32%
Mar 31, 2020 1,234.94%
Dec 31, 2019 -226.82%
Sep 30, 2019 132.66%
Jun 30, 2019 -143.11%
Mar 31, 2019 200.74%
Dec 31, 2018 -228.08%
Sep 30, 2018 725.21%
Jun 30, 2018 -126.81%
Mar 31, 2018 194.98%
Dec 31, 2017 10.65%
Sep 30, 2017 -240.70%
Jun 30, 2017 -38.64%
Mar 31, 2017 302.64%
Dec 31, 2016 -203.88%
Sep 30, 2016 -142.23%
Jun 30, 2016 134.67%
Mar 31, 2016 -311.01%
Dec 31, 2015 402.43%
Sep 30, 2015 129.44%
Jun 30, 2015 29.73%
Mar 31, 2015 -695.18%
Dec 31, 2014 -85.61%
Sep 30, 2014 155.21%
Jun 30, 2014 -187.66%
Mar 31, 2014 138.79%
Dec 31, 2013 -260.46%
Sep 30, 2013 296.10%
Jun 30, 2013 -287.83%
Mar 31, 2013 -53.53%
Dec 31, 2012 1,412.86%
Sep 30, 2012 95.30%
Jun 30, 2012 -768.98%
Mar 31, 2012 -302.72%
Dec 31, 2011 -58.09%
Sep 30, 2011 110.19%
Jun 30, 2011 52.25%
Mar 31, 2011 -174.22%
Dec 31, 2010 409.67%